E Zhu
Curcuma phaeocaulis Val.
Also known as: Zedoary rhizome(English) 莪术(Chinese)
Gajutsu莪朮 ガジュツ(JP: Curcuma zedoaria, C. phaeocaulis or C. kwangsiensis; ChP: C. phaeocaulis, C. kwangsiensis or C. wenyujin (JP adds C. zedoaria, lacks C. wenyujin)) Achul莪朮 아출 O Chu
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
Pregnancy: avoid — strong blood-breaker
With warfarin, coumadin, anticoagulant: blood-moving herb (活血化瘀) → possible additive bleeding risk; no clinical evidence for the class
5 recorded drug interactions, 1 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- regulating blood
- Temperature
- Warm
- Taste
- Pungent,Bitter
- Channels
- Liver,Spleen
Functions
Invigorates Blood and Moves Qi; Disperses Accumulations and Dissipates Nodules; Alleviates Pain; Promotes Digestion and Resolves Food Stagnation
Traditional uses
E Zhu (zedoary rhizome) is a warm, pungent herb that breaks Blood stasis and moves Qi, making it one of the stronger herbs for addressing fixed abdominal masses, tumors, and severe menstrual pain from Blood and Qi stagnation. It also dissolves food stagnation and resolves the accumulation of old, hardened masses. Because of its forceful breaking action, it is used cautiously in debilitated patients and is contraindicated in pregnancy.
Western herbalism
Properties: anti-inflammatory, bitter, carminative
Pharmacological effects
- Antineoplastic and chemopreventive: Curcumol or curdione 75 mg/kg s.c. inhibited sarcoma 37, cervical cancer U14 and Ehrlich ascites carcinoma in mice with local immune reactions; curcumin was antimutagenic, anti-tumor-promoting, and inhibited PMA-induced xanthine oxidase in NIH3T3 cells.
- Prevention of leukopenia: I.p. essential oil or 0.3% curcumol for 8 days offset cyclophosphamide-induced leukopenia in animals.
- Ovary, endometrium and embryo: Ethanolic extract and sesquiterpenes were abortifacient in early-pregnant rats and mice and anti-implantation in dogs; oral suspension 15 g/kg for 4 days in mice caused embryo degeneration.
- Antihepatotoxic: Furanogermenone suppressed CCl4-induced transaminase rises in rats but not other hepatotoxins.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 454.
Formulas using this herb
23 of 23 formulas
- Fu Zheng Yi Yan Tang 扶正抑癌汤
- Guo Qi Yin 过期饮 · 1.50000g · deputy
- Huo Ming Yin 活命饮
- Huo Xue Tong Lin Tang 活血通淋汤
- Huo Xue Zhi Tong Tang 活血止痛汤
- Ji Tong Tang 脊痛汤
- Jian Bi Tang 肩痹汤
- Kai Yu Er Chen Tang · 6.00000g
- Mu Xiang Bin Lang Wan 木香槟榔丸 · 30.00000g · assistant
- Nao Wei Kang Wan 脑萎康丸
- Qing Re Tiao Xue Tang · 3.00000g
- Qing Re Tong Lin Tang 清热通淋汤
- San Jiao Zhu Yu Tang 三焦逐瘀汤
- San Zhong Kui Jian Tang 散肿溃坚汤 · 9.00000g
- Shi Quan Yu Zhen Tang 十全育真汤 · 4.50000g
- Wan Ying Gao · 60.00000g
- Wang Shi Wen Jing Tang · 3.00000g
- Xia Ru Yong Quan San · 10.00000g
- Xia Zhi Sun Shang Xi Fang · 12.00000g
- Xiao Gan Li Pi Tang · 9.00000g
- Xiao San Tang Er Hao 消散汤二号
- Yan Hu Er Hao 延胡二号
- Zhu Yu Tang 逐瘀汤
Botanical
Curcuma phaeocaulis (zedoary, dark-stemmed turmeric) is a robust herbaceous perennial in the Zingiberaceae family, native to subtropical southern China and Southeast Asia, growing 0.9-1.5 m tall from a stout, branching rhizome. The rhizome is large, conical to ovoid, with a grey-brown corky outer surface and a pale yellow to bluish-grey, camphoraceous-smelling, bitter-pungent flesh. The pseudostem, formed by overlapping leaf sheaths, bears 4-7 elongate-lanceolate to oblong leaves 30-60 cm long with a purplish-brown stripe along the midrib. The inflorescence emerges separately from the rhizome before or with the leaves, as a dense cylindrical spike of green bracts tipped with pink to rose-purple coma bracts; the small yellow tubular flowers are nested between the green bracts (POWO; Wikipedia).
- Family
- Zingiberaceae
- Pharmaceutical name
- Rhizoma Curcumae
- Parts used
- rhizome
- Plant type
- herb
Constituents
Curcumol
Guaiane sesquiterpene alcohol
One of the principal sesquiterpenes of the rhizome volatile oil and a constituent of the marketed zedoary turmeric oil preparation. It was among the compounds isolated from the n-hexane fraction of C. phaeocaulis extract in anti-prion screening and is one of the compounds most often credited with the antitumour action of the drug.
Curdione
Germacrane sesquiterpene
A major germacrane sesquiterpene of Curcumae Rhizoma, used together with curcumol as a chemical marker distinguishing the E Zhu drugs from Curcuma longa. It contributes to the anti-inflammatory and blood-moving activity of the essential oil.
Isocurcumenol
Guaiane sesquiterpene
Identified as the representative vasorelaxant compound of C. phaeocaulis essential oil. In isolated rat thoracic aortic rings it relaxes vessels by an endothelium-independent mechanism involving extracellular calcium entry and intracellular calcium release, confirmed by calcium imaging in A7r5 cells. This is a concrete mechanism for the drug's traditional blood-moving action.
beta-Elemene
Elemane sesquiterpene
The sesquiterpene behind the elemene injections and oral emulsions used as chemotherapy adjuvants in China. Derived from C. phaeocaulis it inhibits endometriotic lesion development by inducing ferroptosis through MAPK and STAT3 signalling. Note that the licensed elemene injection is extracted from Curcuma wenyujin, not from C. phaeocaulis, so trial results for the injection are not automatically results for this species.
Curcumenone
Carabrane sesquiterpene
Isolated in a single centrifugal partition chromatography step from the n-hexane fraction of C. phaeocaulis, alongside curcumenol and furanodienone. It was inactive in the prion cell assay in which the other two were active, which is a useful reminder that the sesquiterpene fraction of this drug is not pharmacologically uniform.
Furanodienone
Germacrane sesquiterpene (furanogermacranone)
Identified with curcumenol as one of the two active anti-prion compounds in the C. phaeocaulis hexane fraction in a cell-culture model of prion disease.
Volatile (essential) oil of Curcumae Rhizoma
Sesquiterpene-rich essential oil · the Chinese Pharmacopoeia requires not less than 1.5% (mL/g) volatile oil in Curcumae Rhizoma
The volatile oil is the pharmacopoeial quality determinant and the fraction that carries both the therapeutic and the toxic activity of the drug. In zebrafish, the volatile oil is markedly more toxic than the water decoction, and vinegar processing raises the median lethal concentration of both.
Curcuma phaeocaulis polysaccharides (including the arabinogalactan CPAP-1)
Polysaccharide (arabinogalactan and glucan fractions) · CPAP-1 has an apparent molecular weight of about 118 kDa
Water-soluble polysaccharides of the rhizome are hepatoprotective in vivo, reducing TNF-alpha, IL-1beta and IL-6, raising IL-10, inhibiting TLR4/MyD88/NF-kappaB signalling and modulating the gut barrier and microbiota; the vinegar-processed polysaccharide outperformed the raw one. CPAP-1, an arabinogalactan with a backbone of 3,6- and 3-linked beta-D-galactopyranose, protected endothelial cells against hydrogen peroxide damage at 500 and 750 mg/L. These constituents are present in a decoction and absent from an essential-oil product.
Drug interactions
Curcuma wenyujin and Curcuma kwangsiensis dispensed as E Zhu, and Curcuma longa dispensed as Yu Jin
Moderate · The species actually supplied determines the sesquiterpene profile and the strength of the drug; the genus is a nomenclatural tangle and identity cannot be assumed · Evidence level: Established
The Chinese Pharmacopoeia recognises three botanical sources for Ezhu (Curcumae Rhizoma): Curcuma phaeocaulis, C. kwangsiensis and C. wenyujin. C. phaeocaulis is the geo-authentic Sichuan drug with the longest documented use and the best-studied vinegar processing, but the other two are legally interchangeable in dispensing. The tangle deepens with the root tubers: Curcumae Radix (Yu Jin) is drawn from the same three species plus C. longa, and an ITS2 DNA barcoding study found that while the barcode identified C. kwangsiensis, it could not discriminate C. longa from C. phaeocaulis and failed altogether on DNA-degraded C. wenyujin samples, so the authors had to add headspace GC-IMS volatile profiling. In practice one plant yields two different drugs (rhizome as E Zhu, root tuber as Yu Jin) and one drug name covers several plants.
Clinical note: When a study, a supplement label or a supplier says Curcuma or zedoary, ask which binomial and which organ. Do not read curcumin literature, which is Curcuma longa (Jiang Huang), as evidence for E Zhu: E Zhu is a sesquiterpene drug, not a curcuminoid drug.
Pregnancy
Major · Blood-breaking and uterus-active drug; classically contraindicated in pregnancy · Evidence level: Probable
E Zhu is one of the strongest blood-breaking, mass-dispersing drugs in the materia medica and is contraindicated in pregnancy in standard practice. The pharmacology is consistent: the essential oil of C. phaeocaulis significantly lowered uterine PGF2-alpha and its constituents acted directly on isolated rat uterine smooth muscle contraction in a primary dysmenorrhoea model, and in a blood-stasis rat model raw C. phaeocaulis altered ovarian and uterine coefficients. In zebrafish embryos the volatile oil was frankly embryotoxic, with a median lethal concentration of 67.3 micrograms/mL for the raw oil.
Clinical note: Do not prescribe in pregnancy or when pregnancy is being attempted. Stop it if a patient conceives.
Warfarin, direct oral anticoagulants and antiplatelet agents
Moderate · Possible additive bleeding risk · Evidence level: Possible
E Zhu is used precisely to break blood stasis, and its essential oil is vasorelaxant through an endothelium-independent calcium mechanism. No pharmacokinetic interaction study of C. phaeocaulis with warfarin has been published, so the concern is pharmacodynamic and inferred from the drug class and the vascular pharmacology rather than measured.
Clinical note: Stop before elective surgery. Do not stack with dual antiplatelet therapy or an anticoagulant without monitoring for bruising and, on warfarin, without checking the INR after starting.
Platinum-based and other cytotoxic chemotherapy
Moderate · Used deliberately as an adjuvant in China with reported benefit, but the interaction is with the isolated sesquiterpene, not the crude herb · Evidence level: Probable
Meta-analyses of randomised trials report that elemene injection added to platinum-based chemotherapy in stage III/IV non-small cell lung cancer improves disease control and objective response rates and reduces toxicity, and that elemene added to chemotherapy across cancers improves response rate, immune function and two-year survival while reducing chemotherapy-induced leukopenia. The intervention in all of these is elemene injection, whose active ingredients are beta-, gamma- and delta-elemene extracted from Curcuma aromatica Salisb. (Curcuma wenyujin). A decoction of C. phaeocaulis rhizome is not the same medicine and has not been tested this way.
Clinical note: Do not offer a patient on chemotherapy an E Zhu decoction on the strength of the elemene injection trials, and do not add either during a chemotherapy cycle without the oncology team's knowledge.
Raw versus vinegar-processed E Zhu (Cu E Zhu)
Moderate · The raw drug is the more toxic of the two forms; substituting raw for processed changes the safety margin · Evidence level: Established
Vinegar processing is the standard preparation for the blood-stasis and pain indications, and it measurably reduces toxicity. In zebrafish, the median lethal concentration of the volatile oil rose from 67.315 to 95.755 micrograms/mL after vinegar processing, and that of the water decoction from 161.440 to 206.239 micrograms/mL, with less developmental abnormality in the embryos; the processed products were also less toxic in a blood-stasis rat model while retaining anti-angiogenic activity. Vinegar-processed polysaccharides were the better hepatoprotective of the two.
Clinical note: Specify vinegar-processed E Zhu (Cu E Zhu) when treating stasis pain and masses, which is the classical indication for the processed form, and check that what was dispensed matches. The safety difference is measurable, not notional.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 6–9 g | Daily | 中国药典 2020 【用法与用量】6~9g。 【注意】孕妇禁用。 【性味与归经】辛、苦,温。归肝、脾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value. |
Dui yao: classical pairings
E Zhu + San Leng三棱
Together they break blood stasis and move qi strongly, dissolving accumulations and masses; one is stronger on blood, the other on qi.
Abdominal masses, amenorrhea from stasis and food accumulation with pain. Harsh, draining pair: contraindicated in pregnancy and used with caution in deficiency.
Named pairing — Lü Jingshan, Shi Jinmo Dui Yao
Evidence
Study design on record, not certainty of outcome.
- Systematic review / meta-analysis
- 2
- In vitro / animal
- 5
Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines
Wang X, Liu Z, Sui X, Wu Q, Wang J, Xu C · Phytomedicine · 2019 · systematic review
Systematic review / meta-analysis · Verified
Meta-analysis with trial sequential analysis of 15 randomised trials in 1410 patients with stage III/IV non-small cell lung cancer comparing elemene injection plus platinum-based chemotherapy with chemotherapy alone, reporting disease control rate as the primary endpoint alongside response rate, survival, quality of life, cellular immune function and toxicity. The paper states explicitly that the active ingredients of the injection are beta-, gamma- and delta-elemene extracted from Curcuma aromatica Salisb. (Curcuma wenyujin), which is a different official source species from C. phaeocaulis.
Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis
Pan Y, Wan P, Zhang L, Wang C, Wang Y · Frontiers in Pharmacology · 2023 · systematic review
Systematic review / meta-analysis · Verified
Pooled evidence on elemene injection and oral emulsion as adjuvant therapy in cancer patients on chemotherapy, with GRADE assessment and trial sequential analysis. Elemene improved response rate, immune function measured as CD4+/CD8+ ratio, and two-year survival, and reduced grade III-IV leukopenia and haemoglobin reduction. Again, the medicine is the isolated elemene preparation, not a Curcuma phaeocaulis decoction.
Endothelium-independent vasorelaxant effects of Curcuma phaeocaulis essential oil and its representative compound isocurcumenol
Chen JF, Peng C, Ni H, Li BY, Ye JW, Liu F, Xiong L · Journal of Ethnopharmacology · 2025 · in vitro
In vitro / animal · Verified
In isolated rat thoracic aortic rings, C. phaeocaulis essential oil and isocurcumenol relaxed vessels pre-contracted with potassium chloride or phenylephrine. The effect persisted after endothelium removal and involved both extracellular calcium entry and intracellular calcium release, confirmed by confocal calcium imaging in A7r5 smooth muscle cells. Species is stated explicitly as C. phaeocaulis.
β-elemene, a sesquiterpene constituent from Curcuma phaeocaulis inhibits the development of endometriosis by inducing ferroptosis via the MAPK and STAT3 signaling pathways
Fu Z, Liu H, Kuang Y, Yang J, Luo M, Cao L, Zheng W · Journal of Ethnopharmacology · 2025 · animal
In vitro / animal · Not yet verified
beta-Elemene from C. phaeocaulis inhibited endometriotic lesion development by inducing ferroptosis through MAPK and STAT3 signalling. Provides a mechanism for the classical use of E Zhu, often paired with San Leng, in gynaecological masses.
Isolation of Anti-Prion Compounds from Curcuma phaeocaulis Valeton Extract
Kim J, Lee H, Kim HM, Kim JH, Byun S, Lee S, Kim CY, Ryou C · Molecules · 2024 · in vitro
In vitro / animal · Not yet verified
Centrifugal partition chromatography of the n-hexane fraction of C. phaeocaulis extract yielded curcumenone, curcumenol and furanodienone in a single step. In a cell-culture model of prion disease, curcumenol and furanodienone were the active compounds and curcumenone was not, following an earlier report that the crude extract reduced prion aggregation and propagation in cells and prevented disease onset in three of eight scrapie-inoculated mice.
Extraction optimization, purification, characterization, and hepatoprotective effect of polysaccharides from Curcuma phaeocaulis Val. and its vinegar products
Lin L, Zhu Z, Qing Y, Gao T, Luo Y, Guo T, Chen Y, Xu L, Lou M, Fu C, Liao W · International Journal of Biological Macromolecules · 2025 · animal
In vitro / animal · Verified
Compared polysaccharides from raw and vinegar-processed C. phaeocaulis. Both scavenged DPPH, ABTS and hydroxyl radicals and reduced liver injury in vivo by lowering TNF-alpha, IL-1beta and IL-6, raising IL-10, inhibiting TLR4/MyD88/NF-kappaB signalling and improving the intestinal barrier and gut microbiota, with the vinegar-processed polysaccharide superior. Direct evidence that vinegar processing changes what the drug does, not only how toxic it is.
Structural Characterization and Protective Effects of CPAP-1, an Arabinogalactan from Curcuma phaeocaulis Val., Against H2O2-Induced Oxidative Damage in HUVECs
Long Y, Yi S, Zhou H, Chen F, Guo Y, Guo L · Molecules · 2025 · in vitro
In vitro / animal · Not yet verified
Purified a homogeneous 118 kDa arabinogalactan, CPAP-1, from C. phaeocaulis with a backbone of 3,6- and 3-linked beta-D-galactopyranose. It scavenged DPPH and hydroxyl radicals and, at 500 and 750 mg/L, protected human umbilical vein endothelial cells against hydrogen peroxide damage.
Safety
Contraindications
Its use is prohibited in pregnant women or patients with profuse menstruation.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 252–255.
Side effects
- Curcumol i.v. or intratumoral produced no kidney or liver damage
- Orally, occasional dizziness, nausea and vomiting; some cases of breathing difficulty, burning sensation, palpitation and fatigue
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 454.
⚠ Rule-based cautions
These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.
Pregnancy
Avoid strong blood-breaker
Cultural and historical
Yao Xing Lun · Tang dynasty
Kai Bao Ben Cao · Song dynasty, 973 to 974
Ben Cao Shi Yi · Tang dynasty, Chen Cangqi
References
- Su S, Yang X, Yang M, Zhang Q, Xie J, Chen L, Zhao L, Wang T, Qilatu A, Xu T, Zhang Y. Unlocking the therapeutic potential of Curcuma phaeocaulis Valeton: An integrative review of its ethnopharmacology, processing with vinegar, and pharmacological mechanisms. Journal of Ethnopharmacology. 2026 doi:10.1016/j.jep.2026.122246
- Liao W, Chen Y, Zhu Z, Chen J, Gao T, Limsila B, Techadamrongsin Y, Wang L, Yu J, Fu C, Li R. Vinegar-processed Curcuma phaeocaulis promotes anti-angiogenic activity and reduces toxicity in zebrafish and rat models. Pharmaceutical Biology. 2021 doi:10.1080/13880209.2021.1874427
- Jiang Q, Yin J, Han X, Yong J, Sun R, Liu M, Wang W, Wang Y, Song M, Xiang B, Yu H. Authentication of the Botanical Origins of Curcumae Radix Based on DNA Barcoding and HS‐GC‐IMS. Rapid Communications in Mass Spectrometry. 2026 doi:10.1002/rcm.70160
- Zhu Y, Wu C, Huang Q, Wang J. Spatial distribution of differential metabolites in different parts of Curcuma phaeocaulis Val. using ultra-high-performance liquid chromatography-quadrupole Orbitrap high-resolution mass spectrometry and desorption electrospray ionization mass spectrometry imaging. The Analyst. 2025 doi:10.1039/d5an01077b
- Mi FX, Ni H, Peng C, Liu F, Dai O, Zhou QM, Liu J, Xiong L. [Active constituents of essential oil from Curcuma phaeocaulis for treatment of dysmenorrhea].. China Journal of Chinese Materia Medica. 2024 doi:10.19540/j.cnki.cjcmm.20231211.201